Diligence memo · auto-generated · as of July 2, 2026

White Point Technologies, Inc

White Point Technologies, Inc looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

White Point Technologies, Inc operates in Biotechnology, based in NORTH CHARLESTON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

White Point Technologies, Inc has raised $1.2M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.2M on 2014-03-14.

Most recent recorded round closed around 2014-03-14.

Valuation (modeled)modeled

Provath models White Point Technologies, Inc at approximately $53M (range $864K–$418M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.80× the median modeled value of Seed Biotechnology companies in 2013–2015 (122 peers) — value vs value, same stage and era. Within the normal band (80% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 12.3 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 21% of Biotechnology peers (4293 compared).

Modeled value ranks above 46% of those peers.

Closest niche peers: Harpoon Medical, Inc., Admittance Technologies, Inc., Bell Biosystems, Inc., Nexstim Plc, Iontera, Inc..

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.